Nea Management Company, LLC Top Holdings and 13F Report (2026) About Nea Management Company, LLCInvestment ActivityNea Management Company, LLC has $1.76 billion in total holdings as of March 31, 2026.Nea Management Company, LLC owns shares of 26 different stocks, but just 9 companies or ETFs make up 80% of its holdings.Approximately 11.58% of the portfolio was purchased this quarter.About 26.32% of the portfolio was sold this quarter.This quarter, Nea Management Company, LLC has purchased 27 new stocks and bought additional shares in 2 stocks.Nea Management Company, LLC sold shares of 2 stocks and completely divested from 2 stocks this quarter.Largest Holdings Arcellx $349,656,983Celcuity $260,873,933Spyglass Pharma, Inc. $191,534,519Trevi Therapeutics $157,741,180Savara $133,613,101 Largest New Holdings this Quarter 85220G109 - Spyglass Pharma, Inc. $191,534,519 Holding Largest Purchases this Quarter Spyglass Pharma, Inc. 7,392,301 shares (about $191.53M)Zenas BioPharma, Inc. 500,000 shares (about $9.77M)Korro Bio, Inc. 207,100 shares (about $2.34M) Largest Sales this Quarter Celcuity 1,250,000 shares (about $142.68M)Gossamer Bio 17,093,034 shares (about $5.62M) Sector Allocation Over TimeMap of 500 Largest Holdings ofNea Management Company, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorACLXArcellx$349,656,9830.0%3,045,26219.9%MedicalCELCCelcuity$260,873,933$142,675,000 â–¼-35.4%2,285,56114.8%MedicalSpyglass Pharma, Inc.$191,534,519$191,534,519 â–²New Holding7,392,30110.9%COM SHSTRVITrevi Therapeutics$157,741,1800.0%13,222,2289.0%MedicalSVRASavara$133,613,1010.0%24,471,2647.6%MedicalGLUEMonte Rosa Therapeutics$126,538,3020.0%7,692,2987.2%MedicalMBX Biosciences, Inc.$107,892,4070.0%3,614,4866.1%COMZenas BioPharma, Inc.$78,653,931$9,775,000 â–²14.2%4,023,2194.5%COMCOURCoursera$74,890,4160.0%12,867,7694.3%Business ServicesAUPHAurinia Pharmaceuticals$58,832,9400.0%3,969,8343.3%MedicalORICOric Pharmaceuticals$52,182,9280.0%4,118,6213.0%MedicalCRSPCRISPR Therapeutics$50,356,1750.0%1,058,5702.9%MedicalPHATPhathom Pharmaceuticals$21,777,4780.0%1,960,1691.2%MedicalCVRXCVRx$19,166,7450.0%2,026,0831.1%MedicalKorro Bio, Inc.$14,692,149$2,344,372 â–²19.0%1,297,8930.8%COMXFORX4 Pharmaceuticals$13,355,3590.0%3,233,7430.8%MedicalCSBRChampions Oncology$9,853,8900.0%1,713,7200.6%MedicalBDTXBlack Diamond Therapeutics$9,475,8520.0%4,448,7570.5%MedicalIVAInventiva$8,029,5970.0%1,462,5860.5%MedicalNKTXNkarta$7,530,1280.0%3,568,7810.4%MedicalLeonaBio, Inc.$4,774,0110.0%464,3980.3%COMSenti Biosciences, Inc.$3,065,7990.0%3,775,6150.2%COM NEWMRKRMarker Therapeutics$2,113,3810.0%1,625,6780.1%MedicalOnKure Therapeutics, Inc.$1,981,1890.0%478,5480.1%COM CL AGOSSGossamer Bio$328,500$5,615,062 â–¼-94.5%1,000,0000.0%MedicalImageneBio, Inc.$250,0250.0%50,0050.0%COMRYTMRhythm Pharmaceuticals$0$311,481,690 â–¼-100.0%00.0%MedicalSynlogic, Inc.$0$3,273,505 â–¼-100.0%00.0%COM NEWShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
